Shelf Life Boost For ProteqFlu - From 27 To 36 Months

ProteqFlu, the first and only live attenuated canarypox equine influenza (EI) vaccine, has had its shelf life extended from 27 to 36 months. The move is the result of on-going investment in vaccine research & development, and the new data underpins the stability of this modified live vaccine technology’ says manufacturer, Merial. ProteqFlu is the only equine flu vaccine in Europe to include the updated American clade 1 Ohio/03 strain in accordance with the OIE recommendations (2004).

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards